Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/308% below fair value
$5.84+0.32 (+5.80%)
Close on Nov 13, 2026Market cap $759.10MP/E –Yield –
Cytek Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Cytek Biosciences's operating margin for the twelve months ending Sep 30, 2026 was -21.1%. For fiscal 2025 it was -20.0%, against -10.2% the year before. The highest annual figure on record is 1923.8% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -20.0% | −9.8 |
| FY2024 | Dec 31, 2024 | -10.2% | +4.2 |
| FY2023 | Dec 31, 2023 | -14.4% | −13.3 |
| FY2022 | Dec 31, 2022 | -1.1% | −421.0 |
| FY2021 | Dec 31, 2021 | 419.9% | −1503.9 |
| FY2020 | Dec 31, 2020 | 1923.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -15.8% | +1.8 |
| Q2 FY2026 | Jun 30, 2026 | -23.7% | −0.4 |
| Q1 FY2026 | Mar 31, 2026 | -41.8% | −5.7 |
| Q4 FY2025 | Dec 31, 2025 | -9.0% | −14.2 |
| Q3 FY2025 | Sep 30, 2025 | -17.6% | −9.3 |
| Q2 FY2025 | Jun 30, 2025 | -23.3% | −5.0 |
| Q1 FY2025 | Mar 31, 2025 | -36.1% | −12.2 |
| Q4 FY2024 | Dec 31, 2024 | 5.2% | +5.4 |
| Q3 FY2024 | Sep 30, 2024 | -8.2% | +5.1 |
| Q2 FY2024 | Jun 30, 2024 | -18.3% | +0.1 |
| Q1 FY2024 | Mar 31, 2024 | -23.9% | +8.9 |
| Q4 FY2023 | Dec 31, 2023 | -0.2% | −0.4 |
| Q3 FY2023 | Sep 30, 2023 | -13.4% | −16.7 |
| Q2 FY2023 | Jun 30, 2023 | -18.4% | −16.1 |
| Q1 FY2023 | Mar 31, 2023 | -32.8% | −26.1 |
| Q4 FY2022 | Dec 31, 2022 | 0.2% | −3.2 |
| Q3 FY2022 | Sep 30, 2022 | 3.4% | −5.1 |
| Q2 FY2022 | Jun 30, 2022 | -2.2% | −14.8 |
| Q1 FY2022 | Mar 31, 2022 | -6.7% | −11.4 |
| Q4 FY2021 | Dec 31, 2021 | 3.4% | −22.3 |
| Q3 FY2021 | Sep 30, 2021 | 8.4% | −18.3 |
| Q2 FY2021 | Jun 30, 2021 | 12.5% | +13.7 |
| Q1 FY2021 | Mar 31, 2021 | 4.7% | – |
| Q4 FY2020 | Dec 31, 2020 | 25.7% | – |
| Q3 FY2020 | Sep 30, 2020 | 26.7% | – |
| Q2 FY2020 | Jun 30, 2020 | -1.1% | – |
See a number that looks wrong?